(Q40305286)

19 September 2017

title

Sublingual misoprostol versus intramuscular oxytocin for prevention of postpartum hemorrhage in low-risk women (English)

1 reference

19 September 2017

0 references

1 reference

1 reference

Picklu Chaudhuri

1

1 reference

19 September 2017

Jhuma Biswas

series ordinal

2

1 reference

19 September 2017

Apurba Mandal

series ordinal

3

1 reference

19 September 2017

publication date

17 November 2011

1 reference

International Journal of Gynecology and Obstetrics

19 September 2017

published in

1 reference

19 September 2017

volume

116

1 reference

19 September 2017

issue

2

1 reference

19 September 2017

page(s)

138-142

1 reference

The postpartum period: the key to maternal mortality

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2011.09.016

Misoprostol versus oxytocin in the third stage of labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2011.09.016

Misoprostol in the management of the third stage of labour in the home delivery setting in rural Gambia: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2011.09.016

Oral misoprostol in preventing postpartum haemorrhage in resource-poor communities: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2011.09.016

Oral misoprostol for prevention of postpartum hemorrhage by paramedical workers in India

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2011.09.016

Misoprostol versus oxytocin for the reduction of postpartum blood loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2011.09.016

Administration of misoprostol by trained traditional birth attendants to prevent postpartum haemorrhage in homebirths in Pakistan: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2011.09.016

Rectal misoprostol versus intravenous oxytocin for prevention of postpartum hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2011.09.016

Pharmacokinetics of different routes of administration of misoprostol

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2011.09.016

Sublingual misoprostol versus oxytocin infusion to reduce blood loss at cesarean section

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2011.09.016

The effect of sublingual misoprostol versus intravenous oxytocin in reducing bleeding after caesarean section

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2011.09.016

A pilot-randomized comparison of sublingual misoprostol with syntometrine on the blood loss in third stage of labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2011.09.016

Sublingual misoprostol versus methylergometrine for active management of the third stage of labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2011.09.016

Effect of sublingual misoprostol on severe postpartum haemorrhage in a primary health centre in Guinea-Bissau: randomised double blind clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2011.09.016

A randomized controlled trial of prophylactic sublingual misoprostol versus intramuscular methyl-ergometrine versus intramuscular 15-methyl PGF2alpha in active management of third stage of labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2011.09.016

Comparison of sublingual misoprostol, intravenous oxytocin, and intravenous methylergometrine in active management of the third stage of labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2011.09.016

Administration of 400 μg of misoprostol to augment routine active management of the third stage of labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2011.09.016

A double-blind, randomized, placebo-controlled trial of misoprostol and routine uterotonics for the prevention of postpartum hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2011.09.016

The effect of misoprostol on postpartum contractions: a randomised comparison of three sublingual doses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2011.09.016

10.1016/J.IJGO.2011.09.016

21 January 2018

Identifiers

DOI

1 reference

19 September 2017

1 reference